Uncategorized

Onesource Specialty Pharma up 5% in weak market; rallies 21% in one week (Soban News)

The company will continue to derive strength from the existence of experienced promoters and positive outlook for the GLP1 segment, which is expected to yield revenue to the company from FY27 onwards.​The company will continue to derive strength from the existence of experienced promoters and positive outlook for the GLP1 segment, which is expected to yield revenue to the company from FY27 onwards. ​Latest News [ SOBAN NEWS: International and National ]

Related posts

Vinay Tonse appointed CEO, Yes Bank’s new bet to revive growth momentum (Soban News)

News-Soban-Admin

India leads in making AI affordable, accessible, and scalable: USISPF chief (Soban News)

News-Soban-Admin

Talaq-e-Hasan under SC lens: How it is different from Talaq-e-Biddat (Soban News)

News-Soban-Admin

Leave a Comment